Sava Infond d.o.o. »

Alnylam Pharmaceuticals shares owned by Sava Infond d.o.o.

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Sava Infond d.o.o. from 13F filings

Historical chart of Sava Infond d.o.o. investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Sava Infond d.o.o. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Sava Infond d.o.o.

Quarter filed Position value Share count Share price at filing
2025-09-30 $748k 1.6k 456.00
2025-06-30 $711k 2.2k 326.09
2025-03-31 $562k 2.1k 270.02

More positions owned by Sava Infond d.o.o.

NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Servicenow (NOW)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Meta Platforms Cl A (META)
Amazon (AMZN)
Apple (AAPL)
Palo Alto Networks (PANW)
salesforce (CRM)
Marvell Technology (MRVL)
Applied Materials (AMAT)
MercadoLibre (MELI)

View all positions for Sava Infond d.o.o.

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals